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Purpose: To examine the effect of panretinal photocoagulation (PRP) on the retinal nerve fiber layer (RNFL) 
thickness in patients with diabetic retinopathy.
Methods: Subjects included 118 eyes for a treatment group and 164 eyes for a control group. The peripapillary 
RNFL thickness was measured before and 6 months after PRP in treatment group. In control group, the 
peripapillary RNFL thickness was measured at baseline and 6 months later. The relationships between changes in 
RNFL thickness and the number of laser burns, duration of diabetes, HbA1c level, and vision change were 
analyzed.
Results: After 6 months, the RNFL thickness decreased an average of 2.12 µm and 0.93 µm in the treatment and 
control groups. However, the changes between the two groups were not statistically significant. The relationship 
between the number of laser burns and changes in RNFL thickness was not significant. No differences were found 
between changes in the RNFL thickness and the duration of diabetes in either group. However, in the treatment 
group a higher HbA1c level was correlated with a greater decrease in post-PRP RNFL thickness. This relationship 
was not observed in the control group. The difference in the change of the RNFL thickness between the two 
groups was statistically significant. Vision increased an average of 0.02 and 0.01 after 6 months in the treatment 
and control groups, respectively. However, this difference was not statistically significant. 
Conclusions: Although a decrease in peripapillary RNFL thickness was observed in the treatment group after 6 
months, it was not statistically significant compared to control group. However, the decrease was greater when the 
blood HbA1c level was higher. 
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Panretinal photocoagulation (PRP) reduces the risk of severe 
visual loss by 50% in patients with diabetic retinopathy.
1 
Most physicians agree that the intensity of a laser is enough 
to stimulate the outer retinal layer.
2 If the laser intensity is too 
strong and destroys the entire retinal layer, it will cause a 
sequential decrease in the peripapillary retinal nerve fiber 
layer (RNFL) thickness. Also, it is reasonable to hypothesize 
that the peripapillary RNFL thickness should decrease in 
proportion to the frequency of the laser burns. Most physicians 
perform PRP as a first line strategy in the treatment of diabetic 
retinopathy; however, no reports have investigated peripapillary 
RNFL thickness change following PRP.
The goal of this study is to evaluate the peripapillary RNFL 
thickness after PRP in patients with diabetic retinopathy. 
We also examined possible relationships between changes 
in peripapillary RNFL thickness and 1) HbA1c level, 2) 
diabetes duration, and 3) interval visual acuity.
Materials and Methods
The medical records of patients with diabetic retinopathy 
were reviewed retrospectively. The subjects were divided 
into a treatment group and a control group. The treatment 
group included patients who had received PRP. All patients 
in the treatment group had at least severe non-proliferative 
diabetic retinopathy and received PRP treatment. All patients 
received a moderate degree of laser burns from an argon laser 
photocoagulator (Coherent Ultima 2000, CA, USA). A laser Korean J Ophthalmol Vol.23, No.1, 2009
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Table 1. Baseline data of the treatment group and the control group
Treatment group Control group p
Number of eyes 118 164
Age (mean, years)   59.2±10.1 56.1±9.8  0.853
Duration of diabetes (mean, years) 12.6±6.2   6.8±4.2 <0.001*
BCVA   0.34±0.12   0.86±0.14 <0.001*
BCVA=best corrected visual acuity.
* p<0.05, t-test was performed between the treatment group and the control group
Table 2. Interval changes of peripapillary RNFL thickness in the treatment and control groups
Number of
eyes
Number of
laser burns
RNFL thickness
at baseline (µm)
RNFL thicknes
 at 6 months (µm)
RNFL thickness 
difference* (µm) p  p
‡
Treatment group 118 1576.5±415.7  348.5±48.1 346.4±53.4 2.12±7.34 <0.001
†
0.31
Control group 164 no 364.2±54.2 363.3±58.1 0.93±4.24 0.127
RNFL= retinal nerve fiber layer; PRP=panretinal photocoagulation.
*RNFL thickness at 6 months – RNFL thickness at baseline
† p<0.05, t-test was performed between baseline and 6 months
‡ p value, ANOVA was performed between the treatment group and the control group
Table 3. Interval changes of visual acuity in the treatment group and the control group
Number of
eyes
Number of
laser burns
BCVA at baseline,
mean
BCVA at 6 months, 
mean
Interval difference
of BCVA* pp
‡
Treatment group 118 1576.5±415.7 0.34±0.12 0.36±0.25 0.02±0.10 <0.001
†
0.357
Control group 164 no 0.86±0.14 0.85±0.23 0.01±0.12 0.248
PRP=panretinal photocoagulation; BCVA=best corrected visual acuity.
* BCVA at 6 months – BCVA at baseline
† p<0.05, t-test was performed between baseline and 6 months
‡ p value, ANOVA was performed between the treatment group and the control group
burn of a moderate degree refers to a laser burn resulting in a 
hazy, mucoid, translucent, and foggy chorioretinal lesion. 
The control group included patients with moderate or mild 
non-proliferative diabetic retinopathy who did not receive 
laser treatment. Eyes which had any condition that could 
influence the peripapillary RNFL thickness were excluded from 
the study. The peripapillary RNFL thickness was measured 
before and 6 months after PRP in the treatment group. In the 
control group, the peripapillary RNFL thickness was measured 
at the baseline point of the study and 6 months later. The 
peripapillary RNFL thickness was measured with Stratus 
optical coherence tomography (OCT) 3 (Carl Zeiss Meditec, 
Dublin, CA, USA). Collected data included age, gender, 
duration of diabetes, level of blood glycosylated hemoglobin 
(HbA1C), total number of laser burns, and best corrected 
visual acuity. The final sample included 118 eyes (59 patients) in 
the treatment group and 164 eyes (82 patients) in the control 
group. A series of ANOVA and t-tests were conducted using 
SPSS to examine 1) a demographic difference between the 
two groups and 2) an interval change inthe peripapillary 
RNFL thickness in both groups. We also examined possible 
relationships between changes in peripapillary RNFL thickness 
and 1) HbA1c level, 2) diabetes duration, and 3) interval 
visual acuity in both groups.
Results
Table 1 shows the demographic data of the 118 eyes from 
the 59 PRP-treated subjects and the 164 eyes of the 82 control 
subjects. There were no differences in age or gender between 
the two groups. However, in the treatment group the duration 
of diabetes was longer and the best corrected visual acuity 
was lower than in the control group. These differences were 
statistically significant (p<0.001).
In the treatment group the post-PRP peripapillary RNFL 
thickness decreased an average of 2.12 µm (348.5±48.1 µm 
at baseline to 346.4±53.4 µm 6 months later, p<0.001), while 
an average decrease of 0.93 µm (364.2±54.2 µm at baseline 
to 363.3±58.1 µm 6 months later p=0.127) was observed in 
the control group (Table 2). However, the changes were not 
statistically different between the two groups (p=0.31, Table 
2). In addition, there was no significant relationship between 
the number of laser burns and changes in the peripapillary 
RNFL thickness in the treatment group (p=0.511, ANOVA).
In the treatment group the post-PRP visual acuity increased 
an average of 0.02 (0.34±0.12 at baseline to 0.36±0.25 6 months 
later, p<0.001, Table 3). Despite a significant increase in visual 
acuity, there was no significant relationship between the 
number of laser burns and changes in visual acuity (p=0.873, 
ANOVA). In the control group, visual acuity at 6 months had HY Kim and HK Cho. CHANGE OF RETINAL NERVE FIBER LAYER AFTER LASER 
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Table 4. Comparison of interval changes of the peripapillary RNFL thickness according to changes in visual acuity
Interval change  of BCVA
Improved Unchanged Worsened
Treatment group Control group Treatment group Control group Treatment group Control group
Number of eyes 39 6 63 130 16 28
Change of RNFL thickness (µm)* 2.21±8.27 1.02±4.27 1.99±7.92 0.87±5.72 2.18±7.92 0.89±5.24
p <0.05
† 0.165 0.788 0.879 0.058 <0.001
†
p 
‡ >0.05 >0.05 >0.05
RNFL=retinal nerve fiber layer; PRP=panretinal photocoagulation; BCVA=best corrected visual acuity.
* RNFL thickness at 6 months – RNFL thickness at baseline
† p<0.05, t-test was performed between baseline and 6 months
‡ p value, ANOVA was performed between the treatment group and the control group
decreased an average of 0.01, but the change was not significant 
(0.86±0.14 at baseline to 0.85±0.23 at 6 months, p=0.248, 
Table 3). There was no difference between the two groups 
regarding interval changes of visual acuity (p=0.357, Table 3).
The subjects were divided into improved, unchanged, or 
worsened groups according to the interval changes of the 
visual acuity. Among the improved cases the treatment group 
showed a significant decrease of the peripapillary RNFL 
thickness (p<0.05, Table 4). However, there was no significant 
difference between the two groups (p>0.05, Table 4).
There was no significant relationship between changes in 
the peripapillary RNFL thickness and the duration of diabetes in 
either group (p>0.05, ANOVA). However, in the treatment 
group a higher HbA1c level was correlated with a significantly 
greater decrease in post-PRP RNFL thickness (p<0.05, ANOVA). 
This relationship was not observed in the control group.
Discussion
Although PRP has been proven to be an effective treatment 
strategy for severe DR, the laser intensity utilized is decided 
by the physician. Most physicians agree that laser intensity 
which causes damage to the entire retinal layer should be 
avoided. It has been reported that a high intensity laser beam 
can cause destruction of the entire retinal layer, including 
ganglion cells.
3 Damage to ganglion cells results in loss of 
the retinal nerve fiber layer and a sequential decrease in the 
peripapillary nerve fiber layer thickness.
4 In our study, the 
peripapillary RNFL thickness decreased in both the treatment 
and control groups and the difference between the two groups 
was not statistically significant. Therefore, it is difficult to 
conclude that the change in thickness was due to the laser 
treatment. Our study suggests that retinal laser photocoagula-
tion, which can cause laser burns, does not necessarily damage 
the retinal nerve fiber layer if the laser burn is only of a 
moderate degree. However, the results are limited to 6 months 
of follow-up.
There was no relationship between laser burn frequency 
and peripapillary RNFL thickness change in the treatment 
group. This indicates that an adequate intensity of retinal 
laser photocoagulation does not alter retinal function in 
patients with DR.
Parikh et al.
5 suggested that the retinal nerve fiber becomes 
thinner (0.16 µm/year) with age. Our study also confirmed 
that the thickness of the peripapillary retinal nerve fiber 
decreased 0.93±4.24 µm over 6 months in the treatment group. 
The degree of decrease differs from the study by Parikh et al.
5 
because of sample differences. Many researchers, such as 
Lopes et al.
6 and Takahashi et al.,
7 have suggested a relation-
ship between diabetes and retinal nerve fiber loss. Ozdek et 
al.
8 also suggested a strong relationship between diabetic 
retinopathy and retinal nerve fiber loss.
Chihara suggested that risk factors for RNFL defects in 
eyes with diabetes mellitus included a higher level of DR, 
systemic hypertension, and advanced age. However, visual 
acuity, disc size, axial length, and HBA1c level at the time of 
examination did not correlate with RNFL defects.
9 In our 
study, the decrease in peripapillary RNFL thickness was 
more prominent when the blood HbA1c level was higher. In 
patients with diabetes, a high blood HbA1c suggests poor 
blood sugar control. When the blood sugar level is high there 
is an increased vulnerability to tissue viability, this in turn 
makes the retinal nerve fiber layer vulnerable to external 
insults, such as a laser.
In the treatment group, there was no relationship between 
changes in peripapillary RNFL thickness and changes in vision. 
The laser does not directly treat the fovea; therefore it is 
logical that the visual acuity was not affected.
PRP, which is used to treat diabetic retinopathy, lead to a 
decrease in peripapillary RNFL thickness in the treatment group. 
However, this decrease was not statistically significant when 
compared to the control group. The decrease was greater when 
the blood HbA1c level was higher. Based on this result, we 
suggest that the appropriate timing of PRP treatment may be 
determined after properly reducing the blood HbA1c level if 
other conditions are tolerable.
One limitation of this study is that we only focused on 6 
months of follow-up. Future studies should examine long- 
term results to determine if a similar pattern exists with longer 
follow-up.
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